Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data

被引：0
|
作者：
Tingjian Yan
Mallik Greene
Eunice Chang
Ann Hartry
Maëlys Touya
Michael S. Broder
机构：
[1] Partnership for Health Analytic Research,
[2] LLC,undefined
[3] Otsuka Pharmaceutical Development & Commercialization,undefined
[4] Inc.,undefined
[5] Lundbeck,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Adherence; Bipolar I disorder; Long-acting antipsychotics; Neurology; Schizophrenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1612 / 1625
页数：13
相关论文
共 22 条
  • [11] Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder
    Greene, Mallik
    Yan, Tingjian
    Chang, Eunice
    Hartry, Ann
    Touya, Maelys
    Broder, Michael S.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (02) : 127 - 134
  • [12] HOSPITALIZATIONS IN ADULT PATIENTS WITH SCHIZOPHRENIA TREATED WITH ORAL ATYPICAL ANTIPSYCHOTICS: A REAL-WORLD STUDY USING US CLAIMS DATA
    Yan, T.
    Greene, M.
    Chang, E.
    Houle, C. R.
    Waters, H. C.
    Tarbox, M.
    Broder, M.
    VALUE IN HEALTH, 2019, 22 : S226 - S226
  • [13] The effects of early initiation of aripiprazole once-monthly on healthcare resource utilization and healthcare costs in individuals with schizophrenia: real-world evidence from US claims data
    Waters, Heidi C.
    Stellhorn, Robert
    Touya, Maelys
    Fitzgerald, Heather
    Bhattacharjee, Sandipan
    Citrome, Leslie
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 316 - 325
  • [14] Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study
    Chiappini, Stefania
    Mosca, Alessio
    Miuli, Andrea
    Di Carlo, Francesco
    d'Andrea, Giacomo
    Napolitano, Alessandra
    Santangelo, Monica
    Esposito, Corradina
    Rosazza, Anna
    Haefele, Elena
    Di Petta, Gilberto
    Pettorruso, Mauro
    Sensi, Stefano L.
    Martinotti, Giovanni
    ADVANCES IN DUAL DIAGNOSIS, 2023, 16 (03) : 185 - 198
  • [15] Characteristics of patients in recovery versus patients with recurrence in a randomized placebo-controlled study with aripiprazole once-monthly as maintenance treatment for bipolar I disorder
    Tohen, M.
    Madera, J.
    Such, P.
    Zhang, P.
    Baker, R.
    BIPOLAR DISORDERS, 2018, 20 : 104 - 104
  • [16] Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder
    Doane, Michael J.
    Bessonova, Leona
    Friedler, Haley S.
    Mortimer, Kathleen M.
    Cheng, Harry
    Brecht, Thomas
    O'Sullivan, Amy K.
    Cummings, Hannah
    McDonnell, David
    Meyer, Jonathan M.
    BMC PSYCHIATRY, 2022, 22 (01)
  • [17] Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with bipolar I disorder or schizophrenia
    Doane, Michael J.
    Bessonova, Leona
    Friedler, Haley S.
    Mortimer, Kathleen M.
    Cheng, Harry
    Brecht, Thomas
    O'Sullivan, Amy K.
    Cummings, Hannah
    McDonnell, David
    Meyer, Jonathan M.
    BIPOLAR DISORDERS, 2021, 23 : 83 - 83
  • [18] Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder
    Michael J. Doane
    Leona Bessonova
    Haley S. Friedler
    Kathleen M. Mortimer
    Harry Cheng
    Thomas Brecht
    Amy K. O’Sullivan
    Hannah Cummings
    David McDonnell
    Jonathan M. Meyer
    BMC Psychiatry, 22
  • [19] Real-World Treatment Patterns and Adherence to Oral Medication Among Patients with Bipolar Disorders: A Retrospective, Observational Study Using a Healthcare Claims Database
    Inoue, Takeshi
    Sano, Hiromi
    Kojima, Yoshitsugu
    Yamada, Sakiko
    Shirakawa, Osamu
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 821 - 833
  • [20] Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study
    Kadakia, Aditi
    Dembek, Carole
    Liu, Yi
    Dieyi, Christopher
    Williams, G. Rhys
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1212 - 1220
123